Table 2.
Comparative assessment of Withanolides A and B with Beta, Delta, Gamma and Omicron variants of SARS-CoV-2 spike glycoprotein
S.No. | SARS-CoV-2 variant | PDB ID | Ligand | Binding energy (B.E.) using AutoDock Vina (kcal/mol) | Binding energy (B.E.) using AutoDock v4.2.6 (kcal/mol) | Kd (dissociation constant) |
---|---|---|---|---|---|---|
1. | Betaa | 6M0J | Withanolide A | −9.3 | −9.1 | 214.02 nM |
2. | Betaa | 6M0J | Withanolide B | −9.2 | −8.88 | 308.96 nM |
3. | Gamma | 7EKC | Withanolide A | −8.6 | −4.94 | 240.74 µM |
4. | Gamma | 7EKC | Withanolide B | −7.5 | −5.44 | 102.53 µM |
5. | Delta | 7V7N | Withanolide A | −10.0 | −8.63 | 475.1 nM |
6. | Delta | 7V7N | Withanolide B | −9.6 | −9.27 | 159.47 nM |
7. | Omicron (BA.1) | Modeled Structure | Withanolide A | −9.4 | −7.67 | 2.4 µM |
8. | Omicron (BA.1) | Modeled Structure | Withanolide B | −9.7 | −8.09 | 1.17 µM |